Advanced Therapy of Inflammatory Bowel Disease-2판

INTRODUCTION
1. Patient-Doctor Interactions
2. Pediatric Patient, Family, Doctor Interactions
3. Adherence Issues in Management of Inflammatory Bowel Disease
4. Managing Inflammatory Bowel Disease in the Managed Care Era
5. Medical-Surgical Collaboration in Patient Management
6. Consultations and the Patient with Inflammatory Bowel Disease

DIAGNOSTIC METHODOLOGY
7. Measures of Disease Activity
8. Computer Database for Patients with Inflammatory Bowel
Disease
9. Useful Biologic Markers as Activity Indices
10. Imaging of Mucosal Inflammation
11. Crohn뭩 Disease: Computed Tomographic Scanning in Clinical
Decision Making
12. Transabdominal Bowel Sonography in Clinical Decision-making

PROCTO-SIGMOIDITIS
13. Mode of Action of Anti-inflammatory Agents
14. Management of Distal Colitis
15. Topically Active Corticosteroids for Colitis
16. Pseudo-intractability of Inflammatory Bowel Disease
17. Refractory Distal Colitis
18. Coexistence of Inflammatory Bowel Disease and Irritable
Bowel Syndrome
19. Coexistent Irritable Bowel Syndrome and Inflammatory Bowel
Disease
20. Infectious Agents as Aggravating Factors in Inflammatory
Bowel Disease
21. Use of Nicotine and Tobacco in Colitis
22. Immunomodulator Use in Patients with Distal Colitis
23. Mucosal Protective and Repair Agents in the Treatment of
Colitis

ULCERATIVE COLITIS
24. Therapeutic Expectations: Medical Management of Ulcerative
Colitis
25. Sequential and Combination Therapy of Ulcerative Colitis
26. Ulcerative Colitis: A Diverse Disease with Diverse Questions
and Diverse Solutions
27. Aminosalicylates Therapy for Ulcerative Colitis
28. Systemic Corticosteroids in Inflammatory Bowel Disease
29. Steroid Unresponsiveness in Inflammatory Bowel Disease
30. Immunomodulators in Ulcerative Colitis
31. Management of Severe Ulcerative Colitis
32. Use of Antibiotics and Other Anti-infectious Agents in
Ulcerative Colitis
33. Management of Ulcerative Colitis in Children
34. Indeterminate Colitis
35. Dietary Recommendations for Active and Inactive Ulcerative
Colitis
36. Novel Manipulations of Inflammatory Mediator Pathways

SURGERY FOR ULCERATIVE COLITIS
37. Therapeutic Expectations: Surgical Management of Ulcerative
Colitis
38. Indications for Colectomy and Choice of Procedures
39. Role of the Enterostomal Therapy Nurse
40. Brooke Ileostomy
41. Continent Ileostomy (Kock Pouch)
42. Ileoanal Pouch Anastomosis
43. Long-Term Results with Ileoanal pouch
44. Ileoanal Pouch: Evaluation of Excessive Bowel Movements
45. Ileoanal Pouch Surgery in Childhood
46. Chronic Pouchitis
47. Endoscopy in Evaluating Ileal Pouches
48. Role of the Pathologist in Evaluating Chronic Pouches
49. Support for Patients Who Undergo Ostomy and Pouch Surgery
50. Ileorectal Anastomosis
51. Indeterminate Colitis: Surgical Approaches

COMPLICATIONS OF INFLAMMATORY BOWEL DISEASE
52. Growth and Nutritional Problems in Pediatric Inflammatory
Bowel Disease
53. Dysplasia Surveillance Programs
54. Cancer Prevention Strategies in Inflammatory Bowel Disease
55. Dysplasia Surveillance in Crohn뭩 Disease
56. Extra-intestinal Manifestations
57. Cutaneous Manifestations of Inflammatory Bowel Disease
58. Ocular Manifestations of Inflammatory Bowel Disease
59. Arthritis Associated with Inflammatory Bowel Disease
60. Lessons from Treatment of Rheumatoid Arthritis
61. Osteopenia and Osteoporosis: Prevention and Treatment
62. Ischemic Necrosis of Bone
63. Sclerosing Cholangitis
64. Stricture Management in Primary Sclerosing Cholangitis
65. Liver Transplantation for Primary Sclerosing Cholangitis
66. Cholangiocarcinoma in The Inflammatory Bowel Disease Patient
67. Gallstone Management in Inflammatory Bowel Disease
68. Urologic Complications
69. Hematologic Problems in Inflammatory Bowel Disease
70. Pancreatitis in Inflammatory Bowel Disease

CROHN뭆 DISEASE
71. Cro